Grow Your Pharma Business Digitally
Virtual Booth
Contact Supplier
Product Reset all filters
01 1Tepezza
Teprotumumab-trbw
Amgen
Main Therapeutic Indication : Immunology
Currency : USD
2023 Revenue in Millions : 448
2022 Revenue in Millions : 0
Growth (%) : Acquired from Horizon
Portfolio PDF
Product Web Link
Digital Content
Website
Corporate PDF